A phase 0 exploratory study to assess the pharmacodynamic effects of single intratumoral dose of a novel bispecific targeting/immune-activating agent on the melanoma tumor microenvironment.
L. A. Fecher
Research Funding - Immunocore
Y. McGrath
Employment or Leadership Position - Immunocore
D. D. Williams
Employment or Leadership Position - Immunocore
N. J. Hassan
Employment or Leadership Position - Immunocore
M. Kalos
Research Funding - Immunocore
L. M. Schuchter
No relevant relationships to disclose
R. K. Amaravadi
No relevant relationships to disclose
A. Chew
Research Funding - Immunocore
E. A. Veloso
Research Funding - Immunocore
B. J. Czerniecki
No relevant relationships to disclose
G. Karakousis
No relevant relationships to disclose
G. P. Linette
Research Funding - Immunocore
B. K. Jakobsen
Employment or Leadership Position - Immunocore
Stock Ownership - Immunocore (B)
C. H. June
Research Funding - Immunocore